Yulia Ron

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Henit Yanai, Lev Lichtenstein, Amit Assa et al. · Clinical Gastroenterology and Hepatology · 2014 · 306 citations

Anti-inflammatory, Autoimmune Disease, Immunology +6

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease

Iris Dotan, Yulia Ron, Henit Yanai et al. · Inflammatory Bowel Diseases · 2014 · 277 citations · Full text

Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response

Lior H. Katz, Javier P. Gisbert, Beth Manoogian et al. · Inflammatory Bowel Diseases · 2012 · 130 citations · Full text

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

Uri Kopylov, Yulia Ron, Irit Avni‐Biron et al. · Inflammatory Bowel Diseases · 2017 · 98 citations

Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial

Chen Sarbagili‐Shabat, Franco Scaldaferri, Eran Zittan et al. · Journal of Crohn s and Colitis · 2021 · 94 citations · Full text